TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $470,000 | +179.8% | 6,245 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $168,000 | -47.3% | 6,245 | -6.7% | 0.00% | -50.0% |
| Q4 2021 | $319,000 | -3.0% | 6,692 | +35.2% | 0.00% | 0.0% |
| Q3 2021 | $329,000 | 0.0% | 4,948 | +17.4% | 0.00% | 0.0% |
| Q2 2021 | $329,000 | -25.9% | 4,215 | -10.3% | 0.00% | -33.3% |
| Q1 2021 | $444,000 | -29.0% | 4,698 | -8.4% | 0.00% | -25.0% |
| Q4 2020 | $625,000 | +91.7% | 5,128 | +37.6% | 0.00% | +100.0% |
| Q3 2020 | $326,000 | +229.3% | 3,726 | +141.9% | 0.00% | +100.0% |
| Q2 2020 | $99,000 | +43.5% | 1,540 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $69,000 | -28.1% | 1,540 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $96,000 | – | 1,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |